The DOI matches its Crossref record.
Screening and prevention of diabetic blindness
Abstract
: : Diabetic eye disease remains a major cause of blindness in the world. Laser treatment for proliferative diabetic retinopathy and diabetic macular edema became available more than two decades ago. The outcome of treatment depends on the timing of laser treatment. The laser treatment is optimally delivered when high‐risk characteristics have developed in proliferative retinopathy or diabetic macular edema and before this has significantly affected vision. Laser treatment is usually successful if applied during this optimal period whereas the treatment benefit falls sharply if the treatment is applied too late. In order to optimize the timing of laser treatment in diabetic eye disease screening programs have been established. The oldest screening program is 20 years old and several programs have been established during the last decade. In this paper the organisation and methods of screening programs are described including direct and photographic screening. The incidence and prevalence of blindness is much lower in populations where screening for diabetic eye disease has been established compared to diabetic populations without screening. Technical advantages may allow increased efficiency and telescreening. From a public health standpoint screening for diabetic eye disease is one of the most cost effective health procedures available. Diabetic eye disease can be prevented using existing technology and the cost involved is many times less than the cost of diabetic blindness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The progress in understanding and treatment of diabetic retinopathy
Stitt, A. W., Curtis, T. M., Chen, M., Medina, R. J., McKay, G. J., Jenkins, A., Gardiner, T. A., Lyons, T. J., Hammes, H.-P., Simó, R., et al. (2016) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.08.001 · Cited by 1,164
Diabetic retinopathy - ocular complications of diabetes mellitus
Nentwich, M. M. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i3.489 · Cited by 553
Takase, N., Nozaki, M., Kato, A., Ozeki, H., Yoshida, M., & Ogura, Y. (2015) · Retina · doi:10.1097/iae.0000000000000849 · Cited by 474
Biomarkers in Diabetic Retinopathy
Jenkins, A. J., Joglekar, M. V., Hardikar, A. A., Keech, A. C., O'Neal, D. N., & Januszewski, A. S. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.159 · Cited by 296
Visual impairment and blindness in Europe and their prevention
Kocur, I., & Resnikoff, S. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.7.716 · Cited by 288
Metadata
- Authors
- Stefánsson, E., Bek, T., Porta, M., Larsen, N., Kristinsson, J. K., & Agardh, E.
- Venue
- Acta Ophthalmologica Scandinavica
- Publisher
- Wiley
- Published
- 2000-08
- Volume
- 78
- Issue
- 4
- Pages
- 374-385
- ISSN
- 1395-3907 (ISSN-L)
- 1600-0420
- OpenAlex
- W1964683860
- Cited by
- 292
- References
- 0
- FWCI
- 3.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening and prevention of diabetic blindness. https://app.cochat.ai/papers/10.1034/j.1600-0420.2000.078004374.x
- The paper
- Stefánsson, E., Bek, T., Porta, M., Larsen, N., Kristinsson, J. K., & Agardh, E. (2000). Screening and prevention of diabetic blindness. Acta Ophthalmologica Scandinavica. https://doi.org/10.1034/j.1600-0420.2000.078004374.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.